Senior Research Scientist, Rheumatology
Associate Professor, Division of Rheumatology
Department of Medicine
University of British Columbia

Dr. Jolanda Cibere is a rheumatologist specializing in the research of osteoarthritis, a degenerative disease that is affecting an increasing number of Canadians.

After completing her medical and internal medicine training at the University of Saskatchewan , Dr. Cibere completed her clinical rheumatology training at the University of British Columbia . She also trained in the University of British Columbia 's Department of Health Care and Epidemiology, completed a doctoral program focusing on osteoarthritis, and was awarded an MRC (now CIHR) Clinician Scientist Fellowship award for her studies.

Dr. Cibere pioneered a study on the current use of glucosamine sulfate by osteoarthritis sufferers, the results of which have been widely disseminated to consumers across North America . The 24-week study involving 137 subjects in four Canadian centres, all of who were using glucosamine at the start of the study, found no evidence of benefit from continued use of glucosamine.

Dr. Cibere was the principal investigator for a research study on the early diagnosis of osteoarthritis. Her research led to the development of a standardized knee exam that has since become part of a clinical standard for early detection. She has reported that early knee osteoarthritis can be detected by findings of either joint swelling, gait abnormality or flexion contracture in the knee. She worked with the late Leslie Nielsen to produce a video to help disseminate these results to family practitioners and health care professionals. In addition, her study found that specific blood and urine tests, which detect cartilage breakdown, are useful to identify early osteoarthritis of the knee. She is the principal investigator for ongoing research to investigate the progression of osteoarthritis of the knee after 3 and 6 years, and is involved with similar research on osteoarthritis of the hip.

Dr. Cibere received the Networks of Centres of Excellence Young Innovator Award early in her career. She was awarded a six-year Clinical Scientist Phase II Scholar Award (the highest level salary award given by the Canadian Institutes of Health Research), and received both the UBC's Departmental Faculty Scholar Award and the J. W. McConnell Family Foundation Scholar. She has received a major grant award from The Arthritis Society of Canada to study the earliest phase of osteoarthritis of the knee and a major grant award from the Canadian Institutes of Health Research to assess the long-term progression of osteoarthritis of the knee over 6 years.